On 30 June 2023, the European Parliament and Council of the EU published a regulation which revises the existing mandate of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), in order to keep pace with an ever more complex and rapidly changing drug phenomenon. This regulation entered into force on 1 July 2023. The EMCDDA will become the European Union Drugs Agency (EUDA) on 2 July 2024, the day on which the regulation enters into application.
The new mandate grants the agency considerably more power to perform the tasks needed to address current and future challenges related to illicit drugs. With this more proactive remit, adapted to the current reality, the new EUDA will be better equipped to support the EU and its Member States in addressing emerging issues in this field. This will take place in three key areas: monitoring, preparedness and competence development for better interventions.
The new mandate also includes better cooperation and “co-creating” of EUDA and the civili society organisations.
The agency is currently in a transition period to prepare to implement the new mandate in 2024. As part of that transition process, DPNSEE Executive Director was today with the CSFD Core Group colleagues at the EMCDDA to discuss future cooperation with the civil society. Several other CSFD member organisations’ representatives participated online.
This was the first meeting, where a lot of interesting ideas were thrown at the table. The process will continue throughout this year.
More about the new EUDA mandate is avalable following this webpage>>>.